These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27564651)

  • 1. Refining the risk estimate for transfusion-transmission of occult hepatitis B virus.
    Seed CR; Kiely P; Hoad VC; Keller AJ
    Vox Sang; 2017 Jan; 112(1):3-8. PubMed ID: 27564651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.
    Seed CR; Kiely P
    Vox Sang; 2013 Nov; 105(4):290-8. PubMed ID: 23802710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectivity of blood products from donors with occult hepatitis B virus infection.
    Allain JP; Mihaljevic I; Gonzalez-Fraile MI; Gubbe K; Holm-Harritshøj L; Garcia JM; Brojer E; Erikstrup C; Saniewski M; Wernish L; Bianco L; Ullum H; Candotti D; Lelie N; Gerlich WH; Chudy M
    Transfusion; 2013 Jul; 53(7):1405-15. PubMed ID: 23362802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme.
    Seed CR; Maloney R; Kiely P; Bell B; Keller AJ; Pink J;
    Vox Sang; 2015 Feb; 108(2):113-22. PubMed ID: 25234417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
    Keechilot CS; Shenoy V; Kumar A; Biswas L; Vijayrajratnam S; Dinesh K; Nair P
    Pathog Glob Health; 2016; 110(7-8):287-291. PubMed ID: 27788631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
    Taira R; Satake M; Momose S; Hino S; Suzuki Y; Murokawa H; Uchida S; Tadokoro K
    Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
    Stolz M; Tinguely C; Fontana S; Niederhauser C
    Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study.
    Mardian Y; Yano Y; Wasityastuti W; Ratnasari N; Liang Y; Putri WA; Triyono T; Hayashi Y
    Virol J; 2017 Oct; 14(1):201. PubMed ID: 29061159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing.
    Miletić M; Bingulac-Popović J; Stojić Vidović M; Hećimović A; Berendika M; Babić I; Đogić V; Samardžija M; Barišić K; Jukić I; Mihaljević I
    Transfus Clin Biol; 2019 Nov; 26(4):257-262. PubMed ID: 31153786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
    van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
    Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.
    Vermeulen M; van Drimmelen H; Coleman C; Mitchel J; Reddy R; Lelie N
    Transfusion; 2014 Oct; 54(10):2496-504. PubMed ID: 24749834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.